NCT02688868View on ClinicalTrials.gov

Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 )

NACompletedINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

May 31, 2014

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2020

Conditions
Coronary Heart Disease
Interventions
DEVICE

FirehawkTM 2.25mm

Implantation of the released specification (2.25mm) of FirehawkTM rapamycin target-eluting coronary stent systems

Trial Locations (1)

100037

Fu Wai Hospital, Beijing

All Listed Sponsors
lead

Shanghai MicroPort Medical (Group) Co., Ltd.

INDUSTRY

NCT02688868 - Evaluation of New Specifications (2.25mm) of FirehawkTM in the Treatment of Coronary Heart Disease ( Firehawk_2.25 ) | Biotech Hunter | Biotech Hunter